ABSTRACT OBJECTIVES This study sought to determine the contemporary clinical characteristics and outcomes of patients with ST-segment elevation myocardial infarction (STEMI) and previous coronary artery bypass graft (CABG), including those with a saphenous vein graft culprit lesion.
Baseline electrocardiogram (ECG) morphology, coronary artery, and bypass graft anatomy are frequently abnormal and unknown. Current guidelines advocate rapid activation of the catheterization lab or emergency transport to a facility capable of performing percutaneous coronary intervention (PCI), which may preclude thorough review of previous ECG and operative reports (1). Reports have described higher rates of "false-positive" activation of the cardiac catheterization lab (2) , an increased burden of comorbid illness, and worse clinical outcomes among patients with previous CABG. In fact, previous CABG has been reported to be an independent risk factor for adverse clinical outcomes in patients with STEMI (3) (4) (5) .
Patients with previous CABG compose a small percentage of all patients who present with STEMI, and this subset of patients has not been well characterized. In STEMI patients with previous CABG undergoing primary balloon angioplasty, the in-hospital and 6-month mortality was increased compared with that of patients without previous CABG, especially when the culprit was a saphenous vein graft (SVG) (6) . Bare-metal stent placement was subsequently demonstrated to be superior to balloon angioplasty, with respect to major adverse cardiac outcomes (MACE), in the treatment of obstructed venous bypass grafts (7) . Drug-eluting stents were then shown to be superior to bare-metal stents in the treatment of SVG lesions (8) .
Previous reports, including post-hoc analyses of randomized clinical trials, have described lower rates of primary PCI and/or inferior clinical outcomes after STEMI in patients with previous CABG, especially those with a SVG culprit lesion (9) (10) (11) (12) (13) .
Based on available data, STEMI in the setting of previous CABG or STEMI with the presence of culprit lesion in a bypass graft may confer an increased rate of morbidity and mortality. However, the literature remains limited and is confounded by lower rates of intervention among those with previous CABG.
In addition, significant advancements have been made in stent design, adjunctive pharmacology, and development of regional STEMI systems. Therefore, our goal was to determine the contemporary outcome of patients with previous CABG who presented with STEMI.
METHODS
The Minneapolis Heart Institute at Abbott North- inappropriate (e.g., advanced dementia or widely metastatic cancer). All patients, including those with advanced age, out-of-hospital cardiac arrest, and cardiogenic shock were included in the data analysis (15) . All patients included in the database received emergent coronary angiography unless they expired during transport to the cardiac catheterization laboratory. Institutional review board approval was obtained, including waiver of consent for in-hospital data collection, data analysis, and follow-up up to 5 years. 
RESULTS
Of 3,542 consecutive patients with STEMI, 249 (7%) had a history of previous CABG. These patients were older, more likely male, with increased prevalence of previous MI, PCI, and some cardiovascular risk factors, including diabetes mellitus, but with lower current smoking rates ( Table 1 ). The incidence of anterior MI was higher in patients without previous CABG (35.5% vs. 23.6%; p < 0.001), which is likely due to the presence of left internal mammary artery grafts. There was Table 2 ).
MACE at 30 days (including stroke, recurrent infarction, recurrent ischemia, or death) and rates of hospital readmission at 30 days for cardiac causes were equivalent in the 2 groups. At 1 year, no significant Values are n (%), median (interquartile range), or mean AE SD. *Door-to-balloon time represents the total time from presentation at a referral emergency department or hospital to the first device at the PCI hospital, including time for transport to Abbott Northwestern Hospital. Patients who expired prior to coronary angiography are included in the database for calculation of mortality, but they are not assigned a door to balloon time. †Fisher exact test used to assess statistical significance. ‡Percentage based on those patients alive at discharge. In our study, the rate of primary PCI among patients with previous CABG was lower, albeit to a smaller degree, when patients with no clear culprit artery are censored (88.4% vs. 95.4%, p < 0.001).
There were, however, no significant differences in post-PCI TIMI flow grades between the 2 groups, as was described in previous studies, suggesting that clinical outcomes may be equalized if comparable reperfusion is achieved with current therapies. Values are n (%), median (IQR), or mean AE SD. *Fisher exact test used to assess statistical significance. †Superscripts that are the same do not statistically differ. ‡Door-to-balloon time represents the total time from presentation at a referral emergency department or hospital to the first device at the PCI hospital, including time for transport to Abbott Northwestern Hospital. Patients who expired prior to coronary angiography are included in the database for calculation of mortality, but they are not assigned a door-to-balloon time. §Percentage based on those patients alive at discharge. Tables 1 and 2 .
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